Recognition and Handling of Discordant Negative Human Epidermal Growth Factor Receptor 2 Classification by Oncotype DX in Patients With Breast Cancer

Abstract

REFERENCES 1. Blumenfeld Z: Gonadotropin-releasing hormone agonist for preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer. J Clin Oncol 30:3310, 2012 2. Tomao F, Benedetti Panici P, Tomao S: Gonadotropin-releasing hormone agonists for the preservation of ovarian function during chemotherapy. J Clin Oncol 30:3310, 2012 3. Munster PN, Moore AP, Ismail-Khan R, et al: Randomized trial using gonadotropinreleasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer. J Clin Oncol 30:533-538, 2012 4. Badawy A, Elnashar A, El-Ashry M, et al: Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: Prospective randomized study. Fertil Steril 91:694-697, 2009 5. Del Mastro L, Boni L, Michelotti A, et al: Effect of the gonadotropinreleasing hormone analogue triptorelin on the occurrence of chemotherapyinduced early menopause in premenopausal women with breast cancer: A randomized trial. JAMA 306:269-276, 2011 6. Gerber B, von Minckwitz G, Stehle H, et al: Effect of luteinizing hormone– releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: The GBG 37 ZORO study. J Clin Oncol 29:2334-2341, 2011 7. Leonard RC, Adamson D, Anderson R, et al: The OPTION trial of adjuvant ovarian protection by goserelin in adjuvant chemotherapy for early breast cancer. J Clin Oncol 28:89s, 2010 (abstr 590) 8. Sukumvanich P, Case LD, Van Zee K, et al: Incidence and time course of bleeding after long-term amenorrhea after breast cancer treatment: A prospective study. Cancer 116:3102-3111, 2010 9. Fornier MN, Modi S, Panageas KS, et al: Incidence of chemotherapyinduced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane. Cancer 104:1575-1579, 2005